142 results on '"SSTR4"'
Search Results
2. Venom-inspired somatostatin receptor 4 (SSTR4) agonists as new drug leads for peripheral pain conditions
3. 'N-(Heterocyclyl And Heterocyclylalkyl)-3-Benzylpyridin-2-Amine Derivatives As Sstr4 Agonists' in Patent Application Approval Process (USPTO 20230192659)
4. Researchers Submit Patent Application, 'N-Heteroarylalkyl-2-(Heterocyclyl And Heterocyclylmethyl) Acetamide Derivatives As Sstr4 Agonists', for Approval (USPTO 20230150981)
5. Somatostatin Receptor Type 4 (SSTR4) Drugs In Development, 2021 Research Report Featuring Eli Lilly and Co, GlyTech, Peptide Logic, Strongbridge Biopharma - ResearchAndMarkets.com
6. Research Reports from First Affiliated Hospital Provide New Insights into Alcoholism (Promoter Specific Methylation of SSTR4 is Associated With Alcohol Dependence in Han Chinese Males)
7. Somatostatin Receptor Type 4 (SSTR4) Drugs In Development, 2021 Research Report Featuring Eli Lilly and Co, GlyTech, Peptide Logic, Strongbridge Biopharma
8. Research and Markets Releases Report: Somatostatin Receptor Type 4 (SSTR4) - Drugs In Development
9. Somatostatin Receptor Type 4 (SSTR4) Market Steady Growth to be Witnessed by 2024
10. Somatostatin Receptor Type 4 (SSTR4) Market Steady Growth to be Witnessed by 2024
11. Somatostatin Receptor Type 4 (SSTR4) Market Size, Status and Forecast 2022
12. Centrexion Therapeutics Provides Updates and Advancements for Pipeline of Chronic Pain Treatments
13. Research from University of Antwerp, Department of Veterinary Sciences provides new data on gastroenterology
14. Researchers from University of Antwerp provide details of new studies and findings in the area of inflammation
15. Researchers at University of Porto Zero in on Nerve Tissue Proteins (Alterations of pleiotropic neuropeptide-receptor gene couples in Cetacea)
16. 10-Q: ELI LILLY & CO
17. University of Veterinary Medicine Vienna Researchers Reveal New Findings on Meningeal Neoplasms (Expression of somatostatin receptors in canine and feline meningioma)
18. Patent Issued for Piperidinyl-3-(aryloxy)propanamides and propanoates (USPTO 12005054)
19. Researchers Submit Patent Application, 'Conformational Constrained Somatostatin Receptor 3 Peptide Ligands And Their Conjugates And Uses Thereof', for Approval (USPTO 20240165282)
20. 10-Q: ELI LILLY & CO
21. 10-K: ELI LILLY & CO
22. Fermion announces IND Approval of Non-Addictive Pain Relief Drug FZ008-145 by China NMPA
23. Fermion announces IND Approval of Non-Addictive Pain Relief Drug FZ008-145 by China NMPA
24. Researchers at Nagasaki University Zero in on Biomarkers (Dynamics of somatostatin 4 receptor expression during chronic-stress loading and its potential as a chronic-stress marker)
25. Patent Application Titled 'Livestock Animals With Improved Growth Performance' Published Online (USPTO 20240074415)
26. Alterations of Pleiotropic Neuropeptide-Receptor gene couples in Cetacea
27. Fermion announces IND Approval of Non-Addictive Pain Relief Drug FZ008-145 by China NMPA
28. Patent Issued for Somatostatin modulators and uses thereof (USPTO 11834462)
29. Fermion to Release Updated Data At 2023 BIO International Convention
30. New Genetics Research from Zhongkai University of Agriculture and Engineering Described [Comparative Transcriptome Analyses of Leg Muscle during Early Growth between Geese (* * Anser cygnoides* * ) Breeds Differing in Body Size Characteristics]
31. 10-K: ELI LILLY & CO
32. Researchers Submit Patent Application, 'Stabilized Compositions Of Radionuclides And Uses Thereof', for Approval (USPTO 20230144360)
33. 'Molecular Profiling Of Tumors' in Patent Application Approval Process (USPTO 20230123908)
34. Eli Lilly Places a Small Bet on Confo’s Early-Stage, Non-Opioid Pain Drug
35. 10-Q: ELI LILLY & CO
36. 10-Q: ELI LILLY & CO
37. Patent Application Titled 'Somatostatin Modulators And Uses Thereof' Published Online (USPTO 20230022513)
38. 'Piperidinyl-3-(Aryloxy)propanamides And Propanoates' in Patent Application Approval Process (USPTO 20230021834)
39. Patent Issued for Stabilized compositions of radionuclides and uses thereof (USPTO 11541134)
40. Researchers Submit Patent Application, 'Uses Of A Somatostatin Modulator For The Treatment Of Disease', for Approval (USPTO 20220387420)
41. Researchers Submit Patent Application, 'Somatostatin Modulators And Uses Thereof', for Approval (USPTO 20220380337)
42. Findings on Life Science Reported by Investigators at Polish Academy of Sciences (Habenula As a Possible Target for Treatment-resistant Depression Phenotype In Wistar Kyoto Rats)
43. Patent Issued for Stabilized compositions of radionuclides and uses thereof (USPTO 11497822)
44. 10-Q: ELI LILLY & CO
45. 'Compositions, Methods And Kits For Diagnosis Of A Gastroenteropancreatic Neuroendocrine Neoplasm' in Patent Application Approval Process (USPTO 20220325351)
46. Researchers Submit Patent Application, 'Crystalline Forms Of Somatostatin Modulators', for Approval (USPTO 20220267295)
47. Patent Issued for Somatostatin modulators and uses thereof (USPTO 11414397)
48. 10-K: ELI LILLY & CO
49. Researchers Submit Patent Application, 'Formulations Of A Somatostatin Modulator', for Approval (USPTO 20220143007)
50. 10-Q: ELI LILLY & CO
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.